Compugen (CGEN) Cash & Equivalents (2009 - 2026)

Compugen's Cash & Equivalents history runs 12 years deep, the most recent figure standing at $12.4 million for Q1 2026.

• In Q1 2026, Cash & Equivalents changed N/A year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $12.4 million (changed N/A YoY), while the FY2025 annual figure was $90.6 million, up 396.99% from the prior year.
• Cash & Equivalents came in at $12.4 million for Q1 2026 at Compugen, down from $90.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $90.6 million in Q4 2025 to a low of $11.1 million in Q4 2022.
• A 5-year average of $29.2 million and a median of $13.9 million in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents increased 25.6% in 2023 and jumped 396.99% in 2025, its largest moves.
• Compugen's Cash & Equivalents stood at $11.1 million in 2022, then climbed by 25.6% to $13.9 million in 2023, then surged by 31.24% to $18.2 million in 2024, then surged by 396.99% to $90.6 million in 2025, then sank by 86.27% to $12.4 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $12.4 million, $90.6 million, and $18.2 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison